Doug Phillips

Doug Phillips is a Senior Scientist Antibody Discovery at Mabylon AG, with previous experience as a Scientist II at Cell Medica, Delenex Therapeutics AG, and Expert Scientist at Molecular Partners AG. Before that, Doug was a PhD Student at Cambridge Antibody Technology. Doug holds a PhD in Pharmacy from the University of Reading, an MRes in Biological Sciences from The University of Manchester, and a BSc (Hons) in Medical Biochemistry from the University of Glasgow.